These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12093719)

  • 1. Thrombolysis candidates for the treatment of stroke at an emergency department in Japan.
    Yamaguchi K; Hori S; Nogawa S; Tanahashi N; Fukuuchi Y; Aikawa N
    Acad Emerg Med; 2002 Jul; 9(7):754-8. PubMed ID: 12093719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of increased intravenous tissue plasminogen activator use among hospitals participating in the Massachusetts Primary Stroke Service Program.
    Rost NS; Smith EE; Pervez MA; Mello P; Dreyer P; Schwamm LH
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):314-20. PubMed ID: 22534407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why ischemic stroke patients do not receive thrombolytic treatment: results from a general hospital.
    van den Berg JS; de Jong G
    Acta Neurol Scand; 2009 Sep; 120(3):157-60. PubMed ID: 19719807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-hospital delays to stroke thrombolysis: paradoxical effect of early arrival.
    Romano JG; Muller N; Merino JG; Forteza AM; Koch S; Rabinstein AA
    Neurol Res; 2007 Oct; 29(7):664-6. PubMed ID: 18173904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care.
    Paul CL; Ryan A; Rose S; Attia JR; Kerr E; Koller C; Levi CR
    Implement Sci; 2016 Apr; 11():51. PubMed ID: 27059183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why are eligible thrombolysis candidates left untreated?
    Hills NK; Johnston SC
    Am J Prev Med; 2006 Dec; 31(6 Suppl 2):S210-6. PubMed ID: 17178305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic yield and outcomes of a community teaching hospital code stroke protocol.
    Asimos AW; Norton HJ; Price MF; Cheek WM
    Acad Emerg Med; 2004 Apr; 11(4):361-70. PubMed ID: 15064210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
    Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of intravenous thrombolysis for acute ischemic stroke in Asia.
    Sharma VK; Ng KW; Venketasubramanian N; Saqqur M; Teoh HL; Kaul S; Srivastava PM; Sergentanis T; Suwanwela N; Nguyen TH; Lawrence Wong KS; Chan BP
    Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: Part 1: rapidly improving stroke symptoms.
    ; Levine SR; Khatri P; Broderick JP; Grotta JC; Kasner SE; Kim D; Meyer BC; Panagos P; Romano J; Scott P;
    Stroke; 2013 Sep; 44(9):2500-5. PubMed ID: 23847249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model.
    Zhang L; Zhang ZG; Zhang C; Zhang RL; Chopp M
    Stroke; 2004 Dec; 35(12):2890-5. PubMed ID: 15514182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and feasibility of intravenous rt-PA in the Emergency Department without a neurologist-based stroke unit: an observational study.
    Tampieri A; Giovannini E; Rusconi AM; Cristoni L; Bendanti D; Cenni P; Lenzi T
    Intern Emerg Med; 2015 Mar; 10(2):181-92. PubMed ID: 25430677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use and misuse of thrombolytic therapy within the Veterans Health Administration.
    Keyhani S; Arling G; Williams LS; Ross JS; Ordin DL; Myers J; Tyndall G; Vogel B; Bravata DM
    Med Care; 2012 Jan; 50(1):66-73. PubMed ID: 22182924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Policy: Use of intravenous tPA for the management of acute ischemic stroke in the emergency department.
    ;
    Ann Emerg Med; 2013 Feb; 61(2):225-43. PubMed ID: 23331647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke.
    Savitz SI; Schlaug G; Caplan L; Selim M
    Stroke; 2005 Jul; 36(7):1447-51. PubMed ID: 15947268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality assurance monitoring of a citywide transportation protocol improves clinical indicators of intravenous tissue plasminogen activator therapy: a community-based, longitudinal study.
    Atsumi C; Hasegawa Y; Tsumura K; Ueda T; Suzuki K; Sugiyama M; Nozaki H; Suzuki S; Nakane M; Nagashima G; Kitamura T; Nikaido H; Sasanuma J
    J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):183-8. PubMed ID: 25440326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire.
    Weintraub MI
    Stroke; 2006 Jul; 37(7):1917-22. PubMed ID: 16728683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICU Interventions in Ischemic Stroke Patients Treated Using Liberalized IV-tPA Criteria.
    Murray NM; Ke M; Yee A; Chen C; Wong C; Bedenk A; Fernandes J; Barazangi N; Tong D
    J Stroke Cerebrovasc Dis; 2019 Sep; 28(9):2488-2495. PubMed ID: 31277995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.